City

Baltimore (1)

Boston (1)

Durham (1)

Fitzroy (1)

New York (1)

Condition

IPMN, Pancreatic (3)

IPMN (2)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Duke University (1)

Peking Union Medical College Hospital (1)

St Vincent's Hospital Melbourne (1)

Collaborator

Beijing Hospital (1)

Epworth Healthcare (1)

Johns Hopkins University (1)

Massachusetts General Hospital (1)

Memorial Sloan Kettering Cancer Center (1)

National Cancer Institute (NCI) (1)

The First Affiliated Hospital of Xiamen University (1)

Tongji Hospital (1)

Intervention

endoscopic ultrasound (1)

placebo (1)

sulindac 400 mg (1)

Study Documents

Intervention Type

device (1)

drug (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

ipmn, pancreatic

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cohort Study in Intraductal Papillary Mucinous Neoplasm

Not yet recruiting

IPMN, Pancreatic

Endoscopic ultrasound

(no location specified)

Nov 10, 2022

IPMN, IPMN, Pancreatic Trial in United States (Sulindac 400 MG, Placebo)

Recruiting

IPMN
IPMN, Pancreatic

Sulindac 400 MG
Placebo

Baltimore, Maryland
+3 more

Feb 16, 2022

IPMN, Pancreatic, IPMN Trial in Fitzroy

Recruiting

IPMN, Pancreatic
IPMN

Fitzroy, Victoria, Australia

St Vincent's Hospital Melbourne

Nov 2, 2021